Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
BiomX announced completion of construction of a new state-of-the-art manufacturing facility.
read more
Biond Biologics has entered into an exclusive worldwide license agreement with Sanofi for the development and commercialization of BND-22.
read more
BiondVax developer of the Universal Flu Vaccine candidate M-001, announced the signing of a MSA with a CRO to conduct the first pivotal, clinical efficacy, Phase 3 trial of M-001.
read more
Tuesday, November 03, 2015
Cytovance Biologics, Inc. announced that it has entered into a Development and Manufacturing Agreement for the production of Phase III batches of a universal flu vaccine, M-001, with BiondVax Pharmaceuticals Ltd. (TASE: BVXV) (NASDAQ: BVXV), a ...
read more
Monday, November 20, 2017
BiondVax announced the signing of the clinical trial agreement for a Phase 2 clinical trial with the the U.S. National Institutes of Health.
read more
Thursday, November 10, 2016
Bionical, an integrated outsourced specialist to the pharmaceutical, biotechnology and public health industry, announced the strategic acquisition of Emas Pharma (Emas), a global Clinical Research Organization.
read more
Bionical Emas, a provider of clinical trial services, announced an exclusive global clinical trial supply agreement with Pharma Resources GmbH, German pharmaceutical company and marketing authorization holder, specialized in oncology.
read more
Thursday, December 16, 2021
Bionique Testing Laboratories LLC, a global provider if mycoplasma testing services for the biologics and life- sciences industries, has been 100% acquired by a subsidiary of Japan- based healthcare pioneer Asahi Kasei Medical Co., Ltd. (Asahi Kasei ...
read more
Tuesday, February 03, 2026
Bionique Testing Laboratories announced the appointment of Andy Bailey, PhD, as President and Chief Executive Officer, effective April 1, 2026.
read more
Bionova Scientific has initiated construction of its new biologics manufacturing facility.
read more
Bionova Scientific announced it has licensed ATUM's proprietary Leap-In Transposase® transposon-based gene delivery and its miCHO™ cell line development technologies.
read more
Bionova Scientific, a subsidiary of Asahi Kasei, announced the opening of a 10,000 square-foot plasmid DNA (pDNA) development and production facility in The Woodlands, Texas.
read more
Wednesday, November 25, 2020
Bionova Scientific announced it has secured its first client commitment for GMP clinical supply.
read more
Monday, November 14, 2022
BioNTech announced its Singapore affiliate BioNTech Pharmaceuticals Asia Pacific entered into an agreement with Novartis Singapore Pharmaceutical Manufacturing to acquire one of its GMP-certified manufacturing facilities. Supported by the Singapore ...
read more
Wednesday, September 23, 2020
BioNTech announced the signing of a share purchase agreement with Novartis AG, Basel / Switzerland to acquire their GMP certified manufacturing facility in Marburg, Germany.
read more